Defibrillation Waveform Optimization via Membrane Time Constant

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current implantable cardiac defibrillators (ICDs) face challenges in determining the optimal defibrillation shock waveform for individual patients, as the membrane time constant of cardiac tissue cannot be precisely measured, leading to variable defibrillation thresholds and potential re-initiation of fibrillation due to inappropriate pulse widths.

Innovation Solution

Analyzing cardiac waveforms to determine optimal defibrillation shock waveform parameters, such as pulse widths and tilts, based on characteristics like membrane time constant and system impedance, allowing for personalized waveform optimization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If longer pulse widths are applied to ensure complete depolarization of cardiac tissue, then defibrillation effectiveness is improved, but re-initiation of fibrillation may occur and energy consumption increases

Engineering Contradiction:
Improvedefibrillation effectivenessVSAvoidenergy consumption
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent applies parameter changes by adjusting the pulse width of the defibrillation waveform based on the measured membrane time constant. By changing the pulse width parameter to match the specific patient's cardiac tissue characteristics, the system achieves effective depolarization without excessive energy consumption, resolving the contradiction between reliability and energy use.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If pulse width is increased to depolarize all cardiac tissue cells simultaneously, then defibrillation success rate is improved, but the risk of re-initiation of fibrillation increases

Engineering Contradiction:
Improvedefibrillation success rateVSAvoidre-initiation of fibrillation
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The system changes the pulse width parameter based on the measured membrane time constant to achieve the minimum effective duration needed for simultaneous depolarization. This precise parameter adjustment ensures complete tissue depolarization while minimizing the risk of re-initiation, as the pulse is not excessively long.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If fixed pulse width is used in defibrillation waveform, then device complexity is reduced, but defibrillation threshold becomes variable and effectiveness decreases

Engineering Contradiction:
Improvewaveform parameter controlVSAvoiddefibrillation threshold consistency
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent implements feedback by measuring the membrane time constant from the patient's cardiac waveform and using this measurement to adjust the pulse width parameter. This closed-loop approach ensures consistent defibrillation threshold and effectiveness while adapting to individual patient characteristics, resolving the contradiction between simplicity and reliability.

Inventive Principle:
Principle #23Feedback

4Measurement precision

If membrane time constant is measured accurately, then optimal waveform parameters can be determined, but measurement precision requirements increase system complexity

Engineering Contradiction:
Improvemembrane time constant measurementVSAvoidmeasurement and analysis system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system uses the patient's own cardiac waveform signals to measure the membrane time constant, requiring no external equipment or additional sensors. The defibrillation device itself performs the measurement and analysis, simplifying the overall system while achieving precise characterization of the patient's cardiac tissue.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS8150511B2Systems and methods for determining an optimal defibrillation shock waveform
Publication Date: 2012.04.03 PACESETTER INC
  • US8150511B2 patent drawing
  • US8150511B2 patent drawing
  • US8150511B2 patent drawing

AI summary

Embodiments of the invention present methods and systems for determining an optimal defibrillation shock waveform for application to the heart of a patient to stop a rhythm abnormality such as ventricular fibrillation or ventricular tachycardia. Such methods and systems may include measuring and/or collecting information for a cardiac waveform of a patient, produced as a result of either an electrical stimulus applied to a heart of the patient, which may be a pacing shock/stimulus and/or a defibrillation shock waveform, or as the result of intrinsic cardiac activation, determining a characteristic of the cardiac waveform, comparing the determined characteristic of the cardiac waveform to a plurality of values for the characteristic with optional reference to the defibrillator system impedance, wherein each value of the characteristic is associated with a predetermined value for a parameter of an optimal defibrillation shock waveform, and selecting the predetermined value for the parameter of the optimal defibrillation shock waveform based on the comparison.